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The primary cause of tick-borne relapsing fever in west-
ern North America is Borrelia hermsii, a rodent-associated spi-
rochete transmitted by the fast-feeding soft tick Ornithodoros 
hermsii. We describe a patient who had an illness consistent 
with relapsing fever after exposure in the mountains near Los 
Angeles, California, USA. The patient’s convalescent-phase 
serum was seropositive for B. hermsii but negative for sev-
eral other vector-borne bacterial pathogens. Investigations at 
the exposure site showed the presence of O. hermsi ticks in-
fected with B. hermsii and the presence of rodents that were 
seropositive for the spirochete. We determined that this tick-
borne disease is endemic to the San Gabriel Mountains near 
the greater Los Angeles metropolitan area.
T
ick-borne relapsing fever was first observed in Califor-
nia, USA, in 1921 when 2 persons were infected in a 
cabin in Nevada County, north of Lake Tahoe (1). Anoth-
er 251 cases of relapsing fever were reported in this state 
through 1941. Most persons who became ill had exposures 
at high elevations in various mountain locations (2). Dur-
ing this time, tick-borne relapsing fever was found to be 
endemic near Big Bear Lake in the San Bernardino Moun-
tains, San Bernardino County, in southern California (2,3). 
The first human case in the Big Bear Lake area was report-
ed in 1930 (3); for the next 12 years, more people became 
ill with relapsing fever there than in any other single area 
in the state (2).
The initial human cases of relapsing fever in Califor-
nia preceded identification of the vector, which was dis-
covered to be a previously unidentified tick subsequently 
named Ornithodoros hermsi (4,5). Naturally infected ticks 
that were collected near Big Bear Lake and Lake Tahoe 
transmitted spirochetes in the laboratory when the ticks fed 
on monkeys, mice, and a human volunteer; this transmis-
sion showed the role of O. hermsi ticks as vectors (4,6). 
In 1942, Davis named the O. hermsi tick-associated spiro-
chete Spirochaeta hermsi (7), now recognized as Borrelia 
hermsii (8).
Early investigations of relapsing fever associated with 
O. hermsi ticks at Big Bear Lake and Lake Tahoe were 
seminal  for  defining  the  epidemiologic  parameters  that 
maintain the enzootic foci in these locations and in other 
appropriate  habitats  throughout  western  North  America 
(9). However, since the early field and laboratory studies 
performed in the 1930s, little work has been conducted to 
further elucidate the distribution of B. hermsii in southern 
California. In 1989, a total of 6 persons were infected se-
quentially while staying at different times in the same cabin 
near Big Bear Lake (10), and a year later, 2 persons were 
diagnosed with relapsing fever when they were hospital-
ized in Santa Monica, California, after a weekend visit to 
Big Bear Lake (11). During these outbreaks, ticks were 
not collected and spirochetes were not isolated from the 
patients’ blood. The most recent review of relapsing fever 
that included California reported 95 cases for 1978–1998 
(12). During this 21-year period, 16 (17%) persons were 
infected in San Bernardino County, but no specific loca-
tions were provided.
Information regarding the presence of an enzootic fo-
cus of relapsing fever in Los Angeles County, California, is 
Tick-borne Relapsing Fever and  
Borrelia hermsii, Los Angeles  
County, California, USA
Tom G. Schwan, Sandra J. Raffel, Merry E. Schrumpf, Larry S. Webster, Adriana R. Marques,  
Robyn Spano, Michael Rood, Joe Burns, and Renjie Hu
RESEARCH
1026  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 7, July 2009
Author affiliations: National Institute of Allergy and Infectious Dis-
eases, Hamilton, Montana, USA (T.G. Schwan, S.J. Raffel, M.E. 
Schrumpf); Mt. Wilson Observatory, Mt. Wilson, California, USA 
(L.S. Webster); National Institute of Allergy and Infectious Diseas-
es, Bethesda, Maryland, USA (A.R. Marques); Los Angeles County 
Department of Public Health, Baldwin Park, California (R. Spano, 
M.  Rood);  and  California  Department  of  Public  Health,  Ontario, 
California (J. Burns, R. Hu)
DOI: 10.3201/eid1507.090223Tick-borne Relapsing Fever, California, USA
scant and old. A review published in 2002 showed no cases 
of relapsing fever originating in Los Angeles County dur-
ing the 20th century (13), and a monograph on California 
ticks had no record of O. hermsi ticks being found there 
(14). In 1942, Beck reported 2 cases for 1936–1940 and 
noted that O. hermsi ticks were found in a “nest in garage” 
at an elevation of 2,134 m (7,000 feet) (2). However, no 
additional information was provided, and we are unaware 
of any reports that substantiate the presence of human re-
lapsing fever, O. hermsi ticks, or B. hermsii spirochetes 
near  the  Los  Angeles  metropolitan  area.  The  California 
State and Los Angeles County health statistics units had 
no reports of relapsing fever having ever originated in Los 
Angeles County.
On September 7, 2006, a 51-year-old man cleaned a 
room associated with a 100-year-old solar telescope at Mt. 
Wilson Observatory, located at 1,737 m (5,700 feet) eleva-
tion in the San Gabriel Mountains, Los Angeles County, in 
southern California. Numerous rodent nests were present in 
old cardboard boxes in the room, and the floor was littered 
with rodent feces, acorn husks, and other debris suggest-
ing many years of rodent occupation. On September 9, the 
patient carried several cardboard boxes containing rodent 
nests, and some of the material transferred to his clothing. 
Later that evening, he noticed 2 “insect bites,” 1 on each 
leg, just above the sock line. The bites were asymptomatic 
erythematous macular lesions that enlarged from 2 mm to 
6 mm in diameter over the next few days and faded after 
a week.
On the evening of September 17, the patient experi-
enced a sudden onset of weakness, fever to 38.9°C, shak-
ing chills, and joint and muscle pain; nausea and vomiting 
developed the next day. On September 20, as the illness 
persisted, he sought help at a clinic and was prescribed 
antiemetics, but showed no improvement. On September 
21, as the illness worsened, he sought help at a hospital 
emergency  department.  Physical  examination  indicated 
dehydration and fever (38.9°C). A complete blood count 
showed mild thrombocytopenia and increased granulocyte 
count (Table 1). He was treated with ketorolac, metoclopr-
amide, and intravenous saline for possible viral illness and 
was released. The patient improved over the next several 
days, but his illness relapsed on September 27, when he 
had increased weakness, arthralgias and myalgias, fever, 
shaking chills, and renewed nausea and vomiting. The pa-
tient’s illness peaked on September 28 and improved on 
September 29, but his condition again relapsed on October 
1. The patient returned to the emergency department and 
was hospitalized. Physical examination indicated a tem-
perature of 39.1°C. He was treated with intravenous fluids, 
antiemetics, and piperacillin/tazobactam. Complete blood 
counts showed leukocytosis, left shift, and thrombocytope-
nia (Table 1). Routine blood cultures, which do not support 
borrelia growth, were negative. He improved a few hours 
after receiving antimicrobial drug treatment but was mildly 
hypotensive for a day. The antimicrobial drug was discon-
tinued on October 3, and the patient was again released. 
Night sweats continued for 2 days after discharge, and he 
felt generalized weakness for the next several days. He re-
turned to work full time on October 16.
Methods
Site Investigation
Because of a suspicion that the patient had contracted 
tick-borne relapsing fever, the exposure site was investi-
gated for ticks. A member of our research team (L.S.W.) 
designed a novel tick trap in which a white terry cloth towel 
was wrapped around small blocks of dry ice, which emits 
CO2 and attracts ticks (15). Each trap was taped to the end 
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Table 1. Laboratory test results for 4 dates during illness of patient presumably ill with tick-borne relapsing fever, Los Angeles County, 
California, USA, 2006   
Test Sep 21  Oct 1  Oct 2  Oct 3  Reference range 
Hematocrit, % 43.3 42.3 33.7 33.3 39–55
Erythrocyte count, u 10
–6/mm
3 4.6 4.6 3.6 3.6 4.3–5.9
Platelet count/mm
3 114 145 127 162 130–450
Leukocyte count/mm
3 8.8 11.5 12.8 9.5 4.8–10.8
Neutrophils, % 83 86 64 58 50–70
Band cells, %  5 11 5 0–4
Urea nitrogen, mg/dL  16 10 11 9 6–20
Creatinine, mg/dL  1.2 1.1 1.1 1.0 0.5–1.2
Aspartate aminotransferase, U/L  32 25 29 10–42
Alanine aminotransferase, U/L  68 52 55 10–60
Total bilirubin, mg/dL  2.2 1.5 1.2 0–1.5
Alkaline phosphatase, U/L  206 143 140 42–121
Sodium, mg/dL 134 133 138 140 135–145
Potassium, mg/dL 3.1 3.6 4.5 4.3 3.6–5.0
Glucose, mg/dL 133 112 119 107 70–110
Albumin, g/dL  2.7 2.1 2 3.2–5.5RESEARCH
of a 1-m stick and placed in recesses of the room where 
the patient was potentially exposed to ticks; the traps were 
left overnight and checked the next morning. During sev-
eral nights in late October 2006, the traps collected 6 ticks, 
which  were  sent  to  the  Rocky  Mountain  Laboratories, 
where they were identified as O. hermsi nymphs and tested 
for spirochete infection.
During the nights of June 12–14, 2007, and May 15, 
2008, multiple dry ice traps were set again at the observa-
tory in several buildings with abundant signs of rodent ac-
tivity, including the room that provided the previous ticks. 
One O. hermsi tick was collected in 2007, and 2 nymphs 
were collected in 2008, all from the previously infested 
room where the patient had presumably been bitten.
On  July  16  and  October  23–24,  2008,  Tomahawk 
(Tomahawk  Live  Trap  Co.,  Tomahawk,  WI,  USA)  and 
Sherman (H.B. Sherman Traps, Tallahassee, FL, USA) live 
traps were set on the observatory grounds to capture ro-
dents for serologic testing for antibodies against B. hermsii. 
Whole blood samples were collected from 22 rodents, and 
the serum samples were tested by immunoblot with whole 
cell lysates of B. hermsii and purified recombinant glyc-
erophosphodiester  phosphodiesterase  Q  (GlpQ),  an  im-
munodominant protein in relapsing fever spirochetes but 
absent from Lyme disease spirochetes (16).
DNA Amplification by PCR and Sequence Analysis  
of Spirochetes
DNA was extracted from the 6 ticks collected in Octo-
ber 2006 and examined by PCR and DNA sequence analy-
sis of the 16S rRNA, flagellar B protein (flaB), gyrase B 
(gyrB), glpQ, and variable tick protein (vtp) genes and the 
noncoding intergenic spacer (IGS) locus of B. hermsii by 
using methods described (17–19).
Tick Feeding and Spirochete Isolation
The 3 O. hermsi nymphs collected on June 14, 2007, 
and May 15, 2008, each fed on a laboratory mouse (Mus 
musculus). On days 3–9 after feeding, the mice had ruffed 
hair, and blood collected from the tail vein showed numer-
ous spirochetes per field in a wet preparation viewed by 
dark-field microscopy at 400×. Each mouse was anesthe-
tized, bled by intracardiac puncture, and euthanized, and 
0.2 mL of the blood was passed intraperitoneally into an-
other mouse. The mice were moribund 2 days later and had 
extremely high spirochetemias. The mice were euthanized 
immediately after intracardiac puncture, and the blood sam-
ples were inoculated into Barbour-Stonner-Kelly (BSK)–H 
medium (Sigma-Aldrich Inc., St. Louis, MO, USA) with 
12% rabbit serum for spirochete isolation. Thin smears of 
the infected blood were made on glass microscope slides 
and fixed with methanol to test spirochete reactivity with 
monoclonal antibody H9724, which is specific for all Bor-
relia spp. (20), and monoclonal antibody H9826, which is 
specific for B. hermsii (21). DNA was purified from the 
spirochete cultures for PCR and DNA sequence analysis, 
and aliquots of the cultures were frozen at –80°C. Our work 
with the animals was reviewed and approved by the Rocky 
Mountain Laboratories Animal Care and Use Committee 
(protocol no. 2006–10).
Serologic Tests
A convalescent blood sample was drawn from the pa-
tient on March 17, 2008, after he signed the informed con-
sent under a protocol approved by the National Institute 
of Allergy and Infectious Diseases, National Institutes of 
Health, Institutional Review Board. The serum was tested 
by the indirect immunofluorescent antibody (IFA) assay 
with spirochetes fixed on glass microscope slides, includ-
ing B. hermsii originating from the exposure site, B. herm-
sii  DAH  originating  from  eastern  Washington,  and  the 
Lyme disease spirochete Borrelia burgdorferi B31. The 
serum was also tested with fixed antigen preparations of 
Rickettsia rickettsii, Coxiella burnetii, and Yersinia pestis, 
the agents of Rocky Mountain spotted fever, Q fever, and 
plague, respectively. The serum was tested at 8 serial 2-fold 
dilutions from 1:16 to 1:2,048, and goat anti-human immu-
noglobulin G conjugated with fluorescein isothiocyanate 
(1:100) (Kirkegaard and Perry Laboratories Inc., Gaithers-
burg, MD, USA) was used as the secondary antibody. IFA 
titers were determined by viewing with a Nikon (Tokyo, 
Japan) Eclipse E800 epifluorescence microscope at 600× 
and oil immersion. Serum was also examined at 1:100 di-
lution by immunoblot with whole cell lysates of the same 
spirochete panel and with recombinant GlpQ purified by 
nickel chromatography, as described (16,22).
Results
The patient’s clinical history and the ecologic setting 
of his exposure led us to suspect that he had contracted 
tick-borne relapsing fever, and we initiated a search for 
the tick vector. Six O. hermsi tick nymphs were collected 
with the dry ice traps and pooled for molecular analysis 
to determine presence of spirochete infection. DNA was 
purified from the pooled ticks, and PCR produced ampli-
cons of the appropriate size for all loci examined. DNA 
sequences were determined for the 16S rRNA, flaB, gyrB, 
glpQ, vtp, and IGS loci, which identified the Mt. Wilson 
spirochete (designated MTW-1) as B. hermsii, belonging 
to genomic group II (GG II) (18) (GenBank accession nos. 
EU194839, EU194840, EU194841, EU194842, EU203147, 
and EU203149). The 16S rRNA, glpQ, and IGS sequenc-
es were unique from all other sequences for these loci in 
our B. hermsii isolate collection. These unique sequences 
showed that the PCR products resulted from infected ticks, 
not from laboratory contamination. The vtp sequence was 
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identical to other Type 6 sequences found in genomic group 
I (GG I) spirochetes.
The 3 nymphal O. hermsi ticks collected on June 14, 
2007, and May 15, 2008, each fed on mice (Figure 1) and 
transmitted spirochetes that produced high spirochetemias 
(Figure 2). These spirochetes bound both monoclonal anti-
bodies, which identified the spirochetes as B. hermsii (data 
not shown). Spirochetes grew to high cell density in BSK-H 
medium, and DNA was purified from the second–passage, 
100-mL cultures (23) and designated MTW-2, MTW-3, 
and MTW-4. DNA samples purified from the cultures were 
subjected to PCR, and DNA sequences of the amplicons 
were  determined  for  the  same  6  loci  (GenBank  acces-
sion nos. EU194843, EU194845, EU194846, EU194847, 
EU203148, and EU203150). All sequences determined for 
each locus were identical for the 3 isolates. Sequences for 
the 16S rRNA, flaB, and gyrB genes and for the IGS locus 
were identical to those sequences for MTW-1. This similar-
ity identified MTW-2, MTW-3, and MTW-4 as B. hermsii 
belonging to GG II. The glpQ sequences for MTW-1 and 
for MTW-2, MTW-3, and MTW-4 contained 2 synonymous 
base differences (99.8% identity). However, the vtp DNA 
sequence for MTW-2, MTW-3, and MTW-4 were identi-
cal and unique from all other vtp sequences in the database 
(18), although the sequences showed similarities with other 
Vtp type 5 sequences with 94.6% identity (18). The vtp se-
quences in MTW-1 and MTW-2 represented different Vtp 
types (type 6 and 5, respectively) and shared only 78.5% 
DNA and 69.3% amino acid identities.
Setting the traps resulted in capturing 22 small mam-
mals from 4 species: 14 California ground squirrels (Sper-
mophilus beecheyi), 2 Merriam chipmunks (Tamias mer-
riami), 5 brush mice (Peromyscus boylii), and 1 California 
mouse (Peromyscus californicus). Immunoblot analysis of 
serum samples from the 22 animals showed that 2 of the 
brush mice were strongly reactive with antibody reactivi-
ties equal to those of the positive control sample (Figure 3). 
The other 20 samples were negative. The positive serum 
samples contained antibodies that bound to ≥9 proteins in 
the B. hermsii whole-cell lysates and to the recombinant 
purified GlpQ. The 2 seropositive mice were captured in 
traps set against the exterior walls of the building in which 
the patient was presumed to have been infected.
The patient’s convalescent-phase serum sample was 
seropositive for relapsing fever with the highest IFA titer 
(2,048) to B. hermsii MTW-2 originating from Mt. Wilson 
and with the lowest titers (512 and 128) to B. hermsii DAH 
from eastern Washington and Lyme disease spirochete B. 
burgdorferi, respectively (Table 2). IFA titers were nega-
tive with the other bacterial antigens (Table 2). Immuno-
blots were also positive for antibodies against GlpQ, and 
the serum samples had the strongest reactivity to the Mt. 
Wilson spirochete (data not shown).
Discussion
The diagnosis of relapsing fever was not considered 
during the patient’s illness, and his blood was not examined 
for spirochetes during his acute-phase episodes. Thus, we 
were unable to isolate spirochetes from his blood or obtain 
an acute-phase serum sample to compare with the conva-
lescent-phase sample. However, we conclude that the pa-
tient had contracted relapsing fever on the basis of several 
factors: his clinical history and exposure consistent for this 
disease,  his  recovery  with  antimicrobial  drug  treatment, 
the high IFA titer to B. hermsii, the positive immunoblot, 
the presence of O. hermsi ticks in the room of exposure, 
the presence of B. hermsii in the tick pool, and the isola-
tion of spirochetes that originated from 3 naturally infected 
ticks. Additionally, the patient lived on Mt. Wilson and had 
not traveled recently to other known locations where this 
disease is endemic. Cumulatively, these findings demon-
strate an enzootic focus of tick-borne relapsing fever in Los 
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Figure  1.  Ornithodoros  hermsi  nymphal  tick  from  Mt.  Wilson, 
California, USA. Panel A shows the nymph before its infective blood 
meal; panel B shows it after feeding. Scale bars = 2 mm.
Figure 2. Borrelia hermsii MTW-2 in mouse blood (Wright-Giemsa 
stain) viewed at 600× oil immersion. Scale bar = 40 µm.RESEARCH
Angeles County at a location only 10 km (6.5 miles) from 
downtown Pasadena.
A few vertebrate animals potentially involved with this 
focus  were  investigated.  Douglas  tree  squirrels  (Tamias-
ciurus douglasii), which are important hosts for O. hermsi 
ticks and B. hermsii spirochetes, inhabit the Sierra Nevada 
Mountains to the north but are absent from the San Gabriel 
and San Bernardino Mountains (9,24,25). Other sciurids, 
including  the  California  ground  squirrels  (S.  beecheyi), 
Western  gray  squirrels  (Sciurus  griseus),  and  Merriam 
chipmunks (T. merriami), are abundant on the observatory 
grounds. Several species of mice (Peromyscus spp.) are also 
found at the observatory. In 1947, Longanecker collected 
90 O. hermsi ticks from an active deer mouse nest near Big 
Bear Lake (26). Many larval and nymphal ticks had recently 
fed, and some specimens were infected with spirochetes. 
Our serologic results suggest that brush mice (P. boylii) are 
involved in the enzootic focus on Mt. Wilson.
Western bluebirds (Sialia mexicana) are also abundant 
around the observatory and nest in tree hole cavities. O. 
hermsi ticks have been found in bluebird nests in the Si-
erra Nevada Mountains and in British Columbia, Canada 
(26,27); these birds may also serve as hosts for the ticks in 
this site. Further work is needed to determine the role that 
these and other mammals and birds may play in maintain-
ing the ticks and spirochetes in the mountains of southern 
California.
The investigation provided several results concerning 
the distribution and genetic diversity of B. hermsii. First, 
spirochetes from all ticks from Mt. Wilson belonged to 
GGII, extending south by ≈900 km (560 miles), the known 
geographic distribution of B. hermsii in this genomic group 
(19). Therefore, spirochetes in both genomic groups are 
likely to occur throughout the north-to-south range of these 
organisms in far western North America. Second, GGII spi-
rochetes were found in naturally infected O. hermsi ticks; 
all GGII isolates examined previously came from blood of 
clinically ill patients (19). Third, the Mt. Wilson spirochetes 
MTW-1 and MTW-2 had identical or nearly identical DNA 
sequences at all loci examined except for the variable tick 
protein gene (vtp). The antigenically diverse Vtp sequences 
occurring in ticks in the same location may allow spiro-
chetes of a specific Vtp type to reinfect previously infected 
hosts that are possibly immune to spirochetes of another 
Vtp type (18).
Our study found an enzootic focus of the relapsing fe-
ver spirochete B. hermsii and its tick vector O. hermsi on 
Mt. Wilson near the Los Angeles metropolitan area. The pa-
tient in our study probably contracted relapsing fever there, 
although he was not tested for this infection during his ill-
ness. During the third acute-phase episode, he was hospi-
talized; hospitalization occurs frequently among patients if 
this disease is not diagnosed early. A retrospective analy-
sis of relapsing fever cases in California and Washington 
for 1995–2005 showed that 46% and 80% of cases in each 
state, respectively, required hospitalization (28). Therefore, 
we emphasize that physicians and other healthcare provid-
ers should consider relapsing fever as a possible diagnosis 
when patients seek treatment for an acute, febrile, recurrent 
disease after being exposed in the mountains of southern 
California and other regions where relapsing fever is en-
demic. We also recommend collection of blood samples 
during acute episodes for subsequent analysis and possible 
retrospective clinical testing and diagnosis.
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Figure 3. Immunoblot analysis of serum samples from brush mice 
(Peromyscus  boylii)  and  Merriam  chipmunks  (Tamias  merriami) 
captured  at  Mt.  Wilson  Observatory  in  California,  USA.  Each 
sample was tested at a dilution of 1:100 with a whole-cell lysate 
of Borrelia hermsii MTW-2 isolated from Mt. Wilson (left lane of 
each membrane) and purified recombinant GlpQ (right lane of each 
membrane). Results and animal numbers are presented above and 
below each panel, respectively. Neg, negative; pos, positive.
Table 2. Patient convalescent-phase IFA assay titers to Borrelia 
hermsii and other vector-borne bacterial pathogens, Los Angeles 
County, California, USA, 2006*   
Species IFA titer
B. hermsii MTW-2  2,048
B. hermsii DAH  512
B. burgdorferi B31  128
Rickettsia rickettsii <16
Coxiella burnetii <16
Yersinia pestis <16
*IFA, indirect immunofluorescent antibody. Tick-borne Relapsing Fever, California, USA
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